Evidence map›Paper›PMID 39139018›Full record

ArticleEpilepsia open2024

The thickness of the retinal nerve fiber layer, macula, and ganglion cell-inner plexiform layer in people with drug-resistant epilepsy.

Yujie Chen, Weixi Xiong, Lu Lu, Xintong Wu, Le Cao, Jiani Chen, Yingfeng Xiao, Josemir W Sander, Bo Wu, Dong Zhou

Registry-linked trialAbstract read
In one paragraph

Article in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07716930 (Retina-Based Biomarkers in Epilepsy), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07716930 enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Retina-Based Biomarkers in Epilepsy: Structural and Microvascular OCT Changes and Inflammatory Markers (sCD14, sCD163, CCL2, IL-1β) in Relation to Pathophysiology, Phenotype, Prognosis, and Drug-Resistant Epilepsy (DRE)

TypeobservationalSponsorKemal TutkavulRan2026 to 2028Enrolled250ConditionsEpilepsy (Treatment Refractory), Epilepsy
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yujie ChenLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0002-1056-0840
Weixi XiongLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0001-6835-8664
Lu LuLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0003-3717-5237
Xintong WuLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0002-7676-3288
Le CaoLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0002-0414-9932
Jiani ChenLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0001-7024-1051
Yingfeng XiaoLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.
Josemir W SanderLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0001-6041-9661
Bo WuLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0003-2067-9965
Dong ZhouLondon WC1N 3BG & Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, Chalfont St Peter, Buckinghamshire, UK.ORCID https://orcid.org/0000-0001-7101-4125

Funding

1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University ZY2017305China Postdoctoral Science Foundation 2017M620427Christelijke Vereniging voor de verpleging van Lijdersaan Epilepsie, NetherlandsDr Marvin Weil Epilepsy Research FundNational Institute for Health ResearchNational Natural Science Foundation of China, grants from Post-Doctor Research Project, West China Hospital Sichuan University China 2018HXBH023Postdoctoral Research Foundation of Sichuan University 2018SCU12038UK Epilepsy Society
6 · The paper itself

Abstract

objectiveUsing Optical coherence tomography (OCT), we evaluated the association between peripapillary retinal nerve fiber, macular thickness, macular ganglion cell-inner plexiform layer, and drug resistance.

methodsIn this cross-sectional study, we recruited people diagnosed with epilepsy and healthy controls. People with epilepsy were further stratified as drug-resistant or non-drug-resistant based on their response to anti-seizure medications. OCT measurements were conducted, and findings in right eye were analyzed.

resultsFifty-one drug-resistant participants, 37 non-drug-resistant, and 45 controls were enrolled. The average peripapillary retinal nerve fiber layer, ganglion cell-inner plexiform layer, and macular thickness were thinner in the epilepsy groups than in controls. The drug-resistant group had significantly lower average ganglion cell-inner plexiform layer thickness (p = 0.004) and a higher proportion of abnormal/borderline GC/IPL thickness (p = 5.40E-04) than the non-drug-resistant group. Nevertheless, no significant differences were seen between the average thickness of peripapillary retinal nerve fiber and macular thickness. The temporal sectors of these three parameters were also significantly thinner in the drug-resistant group than in the non-drug-resistant. In a multivariate regression model, drug resistance was an independent predictor of reduced ganglion cell-inner plexiform thickness (Odds ratios OR = 10.25, 95% CI 2.82 to 37.28). Increased seizure frequency (r = -0.23, p = 0.039) and a higher number of anti-seizure medications ever used (r = -0.27, p = 0.013) were negatively associated with ganglion cell-inner plexiform layer thickness. SIGNIFICANCE: Individuals with drug-resistant epilepsy had a consistent reduction in average ganglion cell-inner plexiform layer thickness and the temporal sector of peripapillary retinal nerve fiber layer and macular thickness. This suggests that ganglion cell-inner plexiform layer thickness could potentially serve as an indicator of the burden of drug resistance, as it correlated with reduced thickness in individuals having more frequent seizures and greater exposure to ASMs. PLAIN LANGUAGE SUMMARY: In our study, we used a special tool called OCT to measure how thick the retina is in people with epilepsy and in healthy control. We found that the retina was consistently thinner in all areas for those with epilepsy compared to healthy control. Particularly, a specific layer called the ganglion cell-inner plexiform layer was a lot thinner in the group that didn't respond to medications, and this thinning was related to how often seizures occurred and how much medications were taken. Also, certain parts of the retina were thinner in the drug-resistant group.

Indexed as

Drug Resistant EpilepsyMacula LuteaNerve FibersRetinal Ganglion CellsTomography, Optical CoherenceAdolescentAdultAnticonvulsantsCross-Sectional StudiesFemaleHumansMaleMiddle AgedRetinaYoung AdultAnticonvulsantsdrug resistancenerve degenerationoptical coherence tomography

Identifiers

PMID39139018
PMCPMC11450591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.